StemCell Institute (TSE:7096) Cash Flow for Dividends: 円-0 Mil (TTM As of Mar. 2026)


TSE:7096 StemCell Institute TSE:7096
69 GF Score
Price 円768.00
GF Value 円1,813.82
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is StemCell Institute Cash Flow for Dividends?

StemCell Institute TSE:7096 +0.92% 69 Cash Flow for Dividends is 円-0 Mil as of Mar. 2026. GuruFocus rates TSE:7096 with a GF Score™ of 69/100 and a GF Value™ of 円1,813.82 (Possible Value Trap). The stock has 6 warning signs investors should review.

StemCell Institute's cash flow for dividends for the six months ended in Mar. 2026 was 円-0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was 円-0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

StemCell Institute's quarterly payment of dividends increased from Mar. 2025 (円0 Mil) to Sep. 2025 (円-0 Mil) but then declined from Sep. 2025 (円-0 Mil) to Mar. 2026 (円-0 Mil).

StemCell Institute's annual payment of dividends increased from Mar. 2024 (円0 Mil) to Mar. 2025 (円-256 Mil) but then declined from Mar. 2025 (円-256 Mil) to Mar. 2026 (円-0 Mil).

StemCell Institute Cash Flow for Dividends Related Terms

StemCell Institute Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for StemCell Institute's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemCell Institute Cash Flow for Dividends Chart

StemCell Institute Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -255.83 -0.22

StemCell Institute Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.17 -0.05
TSE:7096
69GF Score
StemCell Institute TSE:7096
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StemCell Institute Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of 円-0 Mil mean?
StemCell Institute (TSE:7096) has a Cash Flow for Dividends of 円-0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for StemCell Institute and its competitors.
Is StemCell Institute's Cash Flow for Dividends too high?
StemCell Institute's current Cash Flow for Dividends is 円-0 Mil. Overall, StemCell Institute has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does StemCell Institute's Cash Flow for Dividends compare to VRTX and REGN?
StemCell Institute's Cash Flow for Dividends of 円-0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for StemCell Institute and its competitors. StemCell Institute's current Cash Flow for Dividends is 円-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemCell Institute stock overvalued right now?
Based on GuruFocus' analysis, StemCell Institute (TSE:7096) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,813.82, compared to a current price of 円768.00 — trading 57.7% below its estimated fair value. The current Cash Flow for Dividends is 円-0 Mil. StemCell Institute's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For StemCell Institute (TSE:7096), the current Cash Flow for Dividends is 円-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is StemCell Institute (TSE:7096) Overvalued in 2026?

Based on GuruFocus' analysis, StemCell Institute stock appears to be undervalued. The current stock price of 円768.00 is trading 57.7% below its estimated GF Value™ of 円1,813.82. GuruFocus considers StemCell Institute to be Possible Value Trap.

Key valuation signals for TSE:7096:

  • Cash Flow for Dividends: 円-0 Mil
  • GF Value™: 円1,813.82 vs. price of 円768.00 (57.7% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the TSE:7096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

StemCell Institute Business Description

Address 1-21-19 Toranomon, Minato-ku, Tokyo, JPN, 105-0001
StemCell Institute is engaged in the Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects the mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood. The Company operates in a single segment, the cell bank business sales consist of three components: technical fees, storage fees, and other fees.
69GF Score

Get the complete analysis for TSE:7096

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円768.00
Price
円1,813.82
GF Value